Have your own idea? Try our Stock Screener
Chinese (SSE) Life Sciences Industry Analysis
UpdatedAug 14, 2025
DataAggregated Company Financials
Companies27
- 7D3.6%
- 3M48.8%
- 1Y100.9%
- YTD60.6%
Over the last 7 days, the Life Sciences industry has remained flat. As for the the longer term, the industry is up 85% over the past 12 months. Looking forward, earnings are forecast to grow by 21% annually.
Industry Valuation and Performance
Has the Chinese Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 14 Aug 2025 | CN¥598.1b | CN¥91.6b | CN¥17.9b | 63.3x | 33.5x | 6.5x |
| Sat, 12 Jul 2025 | CN¥464.3b | CN¥89.8b | CN¥15.4b | 51.8x | 30.2x | 5.2x |
| Mon, 09 Jun 2025 | CN¥421.7b | CN¥89.8b | CN¥15.4b | 48.1x | 27.4x | 4.7x |
| Wed, 07 May 2025 | CN¥397.3b | CN¥89.5b | CN¥15.1b | 41x | 26.3x | 4.4x |
| Fri, 04 Apr 2025 | CN¥425.3b | CN¥88.5b | CN¥14.0b | 43.5x | 30.3x | 4.8x |
| Sun, 02 Mar 2025 | CN¥419.3b | CN¥88.2b | CN¥11.2b | 42.2x | 37.4x | 4.8x |
| Tue, 28 Jan 2025 | CN¥359.2b | CN¥88.1b | CN¥11.2b | 37.6x | 31.9x | 4.1x |
| Thu, 26 Dec 2024 | CN¥373.2b | CN¥87.8b | CN¥11.2b | 38.7x | 33.4x | 4.2x |
| Sat, 23 Nov 2024 | CN¥358.4b | CN¥87.8b | CN¥11.2b | 37.6x | 32x | 4.1x |
| Mon, 21 Oct 2024 | CN¥360.2b | CN¥88.2b | CN¥12.4b | 32.6x | 29.1x | 4.1x |
| Wed, 18 Sep 2024 | CN¥279.8b | CN¥88.2b | CN¥12.4b | 27.5x | 22.6x | 3.2x |
| Fri, 16 Aug 2024 | CN¥284.1b | CN¥87.7b | CN¥12.6b | 26x | 22.6x | 3.2x |
| Sun, 14 Jul 2024 | CN¥279.1b | CN¥88.3b | CN¥13.4b | 24.6x | 20.8x | 3.2x |
| Tue, 11 Jun 2024 | CN¥303.0b | CN¥88.3b | CN¥13.4b | 26.8x | 22.6x | 3.4x |
| Thu, 09 May 2024 | CN¥337.2b | CN¥88.3b | CN¥13.3b | 30.8x | 25.3x | 3.8x |
| Sat, 06 Apr 2024 | CN¥337.9b | CN¥90.3b | CN¥15.0b | 33.6x | 22.5x | 3.7x |
| Mon, 04 Mar 2024 | CN¥364.9b | CN¥90.5b | CN¥15.5b | 31.8x | 23.5x | 4x |
| Wed, 31 Jan 2024 | CN¥367.1b | CN¥91.1b | CN¥16.1b | 32x | 22.8x | 4x |
| Fri, 29 Dec 2023 | CN¥476.5b | CN¥91.1b | CN¥16.1b | 38.2x | 29.6x | 5.2x |
| Sun, 26 Nov 2023 | CN¥535.9b | CN¥91.1b | CN¥16.1b | 39.8x | 33.3x | 5.9x |
| Tue, 24 Oct 2023 | CN¥506.8b | CN¥92.2b | CN¥18.4b | 33x | 27.5x | 5.5x |
| Thu, 21 Sep 2023 | CN¥488.4b | CN¥92.0b | CN¥18.3b | 32.3x | 26.6x | 5.3x |
| Sat, 19 Aug 2023 | CN¥483.0b | CN¥91.6b | CN¥18.6b | 33.3x | 26x | 5.3x |
| Mon, 17 Jul 2023 | CN¥470.9b | CN¥91.3b | CN¥18.5b | 34.9x | 25.5x | 5.2x |
| Wed, 14 Jun 2023 | CN¥486.0b | CN¥91.3b | CN¥18.5b | 36.4x | 26.3x | 5.3x |
| Fri, 12 May 2023 | CN¥506.2b | CN¥91.5b | CN¥18.5b | 39.6x | 27.3x | 5.5x |
| Sun, 09 Apr 2023 | CN¥590.2b | CN¥91.2b | CN¥19.1b | 54.9x | 30.9x | 6.5x |
| Tue, 07 Mar 2023 | CN¥607.2b | CN¥85.5b | CN¥20.0b | 52.1x | 30.4x | 7.1x |
| Thu, 02 Feb 2023 | CN¥678.8b | CN¥86.6b | CN¥20.8b | 56.7x | 32.6x | 7.8x |
| Sat, 31 Dec 2022 | CN¥604.5b | CN¥86.6b | CN¥20.8b | 50.9x | 29.1x | 7x |
| Mon, 28 Nov 2022 | CN¥600.8b | CN¥86.6b | CN¥20.8b | 51.1x | 28.9x | 6.9x |
| Wed, 26 Oct 2022 | CN¥530.3b | CN¥79.0b | CN¥18.8b | 47.5x | 28.2x | 6.7x |
| Fri, 23 Sep 2022 | CN¥526.3b | CN¥77.8b | CN¥17.0b | 47.8x | 30.9x | 6.8x |
| Sun, 21 Aug 2022 | CN¥620.5b | CN¥73.4b | CN¥17.1b | 62.3x | 36.2x | 8.5x |
Price to Earnings Ratio
36.2x
Current Industry PE
- Investors are optimistic on the Chinese Life Sciences industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 32.0x which is higher than its 3-year average PE of 28.5x.
- The 3-year average PS ratio of 5.2x is lower than the industry's current PS ratio of 6.2x.
Past Earnings Growth
- The earnings for companies in the Life Sciences industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have grown 7.7% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.
Industry Trends
Which industries have driven the changes within the Chinese Healthcare industry?
| CN Market | 2.18% | |
| Healthcare | 1.99% | |
| Life Sciences | 3.63% | |
| Clinical Research and Equipment | 3.63% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 603259 WuXi AppTec | CN¥98.12 | 4.9% +CN¥20.4b | 146.1% | PE18.3x | |
| 300347 Hangzhou Tigermed Consulting | CN¥69.00 | 4.5% +CN¥2.6b | 32.2% | PE175.9x | |
| 300759 Pharmaron Beijing | CN¥30.84 | 4.8% +CN¥2.5b | 51.3% | PE29.2x | |
| 603127 Joinn Laboratories(China)Co.Ltd | CN¥34.20 | 9.9% +CN¥2.3b | 130.1% | PE64.7x | |
| 688621 Beijing Sun-Novo Pharmaceutical Research | CN¥71.35 | 13.1% +CN¥904.8m | 94.9% | PE58.1x |